Imatinib
Brand name: Gleevec
Imatinib comes in 39 pill versions in our database, in 2 strengths, from 19 manufacturers. Check the imprint to tell them apart.
Imatinib pill images
100 mg 19 pills
-
IMA 100 APO
Imatinib Mesylate 100 mg
Orange, round, 9 mm
Used for lymphoid leukemia and myeloid leukemia
- S 1 Imatinib Mesylate 100 mg Yellow, round, 7 mm Used for lymphoid leukemia and myeloid leukemia
- 51 Imatinib Mesylate 100 mg Brown, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- 472 Imatinib Mesylate 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- 1 scoreline Imatinib 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- M I 100 Imatinib 100 mg Brown, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- H 7 Imatinib Mesylate 100 mg White, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- CE 138 Imatinib Mesylate 100 mg Orange, round, 7 mm Used for lymphoid leukemia and myeloid leukemia
- 100 Imatinib Mesylate 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- NVR SA Imatinib Mesylate 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- TE VA 7629 Imatinib Mesylate 100 mg Orange, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- IMA 100 APO Imatinib Mesylate 100 mg Brown & orange, round Used for lymphoid leukemia and myeloid leukemia
- 100 N I Imatinib Mesylate 100 mg Brown & orange, round Used for lymphoid leukemia and myeloid leukemia
- FG 1 Imatinib Mesylate 100 mg Orange & yellow, round Used for lymphoid leukemia and myeloid leukemia
- 100 N I Imatinib Mesylate 100 mg Brown & orange, round Used for lymphoid leukemia and myeloid leukemia
- IMA 100 APO Imatinib Mesylate 100 mg Brown & orange, round Used for lymphoid leukemia and myeloid leukemia
- No picture yet DIN 02253275 Imatinib Mesylate 100 mg Gleevec, Tablet, sold in Canada Used for lymphoid leukemia and myeloid leukemia
- No picture yet DIN 02399806 Imatinib Mesylate 100 mg Teva-Imatinib, Tablet, sold in Canada Used for lymphoid leukemia and myeloid leukemia
- No picture yet DIN 02492334 Imatinib Mesylate 100 mg Mint-Imatinib, Tablet, sold in Canada Used for lymphoid leukemia and myeloid leukemia
400 mg 20 pills
- S 2 Imatinib Mesylate 400 mg Yellow, capsule, 16 mm Used for lymphoid leukemia and myeloid leukemia
- 52 Imatinib Mesylate 400 mg Brown, oval, 19 mm Used for lymphoid leukemia and myeloid leukemia
- 475 Imatinib Mesylate 400 mg Yellow, oval, 20 mm Used for lymphoid leukemia and myeloid leukemia
- 4 scoreline Imatinib 400 mg Yellow, oval, 20 mm Used for lymphoid leukemia and myeloid leukemia
- MYLAN I 400 Imatinib 400 mg Brown, oval, 19 mm Used for lymphoid leukemia and myeloid leukemia
- H 4 Imatinib Mesylate 400 mg White, oval, 19 mm Used for lymphoid leukemia and myeloid leukemia
- CE 139 Imatinib Mesylate 400 mg Orange, capsule, 16 mm Used for lymphoid leukemia and myeloid leukemia
- 400 Imatinib Mesylate 400 mg Yellow, oval, 20 mm Used for lymphoid leukemia and myeloid leukemia
- gleevec Imatinib Mesylate 400 mg Yellow, oval, 19 mm Used for lymphoid leukemia and myeloid leukemia
- 400 SL Imatinib Mesylate 400 mg Yellow, oval, 19 mm Used for lymphoid leukemia and myeloid leukemia
- IMA 400 APO Imatinib Mesylate 400 mg Orange, capsule, 17 mm Used for lymphoid leukemia and myeloid leukemia
- TE VA 7630 Imatinib Mesylate 400 mg Orange, capsule, 19 mm Used for lymphoid leukemia and myeloid leukemia
- IMA 400 APO Imatinib Mesylate 400 mg Brown & orange, capsule Used for lymphoid leukemia and myeloid leukemia
- 400 N I Imatinib Mesylate 400 mg Brown & orange, oval Used for lymphoid leukemia and myeloid leukemia
- FG 2 Imatinib Mesylate 400 mg Orange & yellow, oval Used for lymphoid leukemia and myeloid leukemia
- 400 N I Imatinib Mesylate 400 mg Brown & orange, oval Used for lymphoid leukemia and myeloid leukemia
- IMA 400 APO Imatinib Mesylate 400 mg Brown & orange, capsule Used for lymphoid leukemia and myeloid leukemia
- No picture yet DIN 02253283 Imatinib Mesylate 400 mg Gleevec, Tablet, sold in Canada Used for lymphoid leukemia and myeloid leukemia
- No picture yet DIN 02399814 Imatinib Mesylate 400 mg Teva-Imatinib, Tablet, sold in Canada Used for lymphoid leukemia and myeloid leukemia
- No picture yet DIN 02492342 Imatinib Mesylate 400 mg Mint-Imatinib, Tablet, sold in Canada Used for lymphoid leukemia and myeloid leukemia
What is Imatinib used for?
Imatinib is used for lymphoid leukemia, myeloid leukemia and dermatofibrosarcoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Newly Diagnosed Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML)
Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Ph+ CML in Blast Crisis (BC), Accelerated Phase (AP) or Chronic Phase (CP) After Interferon-alpha (IFN) Therapy
Patients with Philadelphia chromosome positive chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.
Adult Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Pediatric Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy.
Myelodysplastic/Myeloproliferative Diseases (MDS/MPD)
Adult patients with myelodysplastic/myeloproliferative diseases associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements.
Aggressive Systemic Mastocytosis (ASM)
Adult patients with aggressive systemic mastocytosis without the D816V c-Kit mutation or with c-Kit mutational status unknown.
Hypereosinophilic Syndrome (HES) and/or Chronic Eosinophilic Leukemia (CEL)
Adult patients with hypereosinophilic syndrome and/or chronic eosinophilic leukemia who have the FIP1L1-PDGFRα fusion kinase (mutational analysis or fluorescence in situ hybridization [FISH] demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRα fusion kinase negative or unknown.
Dermatofibrosarcoma Protuberans (DFSP)
Adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans.
Kit+ Gastrointestinal Stromal Tumors (GIST)
Patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors.
Adjuvant Treatment of GIST
Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.
From the FDA-approved label on DailyMed (published Oct 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.